What is NGNE's dilution risk score?

NGNE currently has a DilutionScore of 48/100, indicating medium dilution risk. DilutionWatch monitors NGNE SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for NGNE?

DilutionWatch tracks 25 SEC filing types for NGNE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NGNE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NGNE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NGNE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NGNE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NGNE Dilution Risk Score: 48/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

10

📊 Float Risk

90

⚠️ Warrant Exposure

50

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

7%

📜 Warrant Exercise 15%

• Warrant overhang: 11.6% of shares outstanding

🔔 Track NGNE — Get forecast alerts →

💹 Market Data

Market Cap$447.83M

Shares Outstanding15.80M

Float6.01M

Cash$243.18M

DebtN/A

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.3% shares (2026Q1 vs prior)

98 institutional holders · 18.82M shares

#1 SAMSARA BIOCAPITAL, LLC 1.72M shares

#2 Redmile Group, LLC 1.46M shares

#3 Casdin Capital, LLC 1.42M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.35M

Days to Cover13.5

% of Float55.8%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2023

xbrl XBRL WARRANT Dec 18, 2023

4 INSIDER TRANSACTION Mar 30, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for NGNE Shareholders

Neurogene Inc. (NGNE) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 1.8M outstanding warrants for NGNE. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for NGNE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NGNE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →